Truth Frequency News
Published on September 8, 2011 by Sheree
USA Today
By HealthDay
Two doses of the human papillomavirus (HPV) vaccine may offer just as much protection against cervical cancer as the three-dose regimen now being used, new U.S. government research shows.
The findings stem from an analysis of data from the National Cancer Institute’s Costa Rica Vaccine Trial, in which 7,466 women were enrolled, according to a news release from the Journal of the National Cancer Institute, which published the results on Thursday.
The women were either given the HPV vaccine Cervarix or a Hepatitis A vaccine. Although researchers intended to give the women receiving Cervarix the full three doses, 20 percent of them got only one dose or two doses for a variety of reasons.
After four years, the researchers found, two doses of Cervarix offered the same level of protection against HPV infection as three. Even one dose offered a high level of protection.
Read Full Article…
Thousands of girls have experienced health problems after only one dose of Gardasil and are naturally reluctant to take a second one.
The fact that Gardasil is a very painful injection also contributes towards reluctance to continue with several doses.
Note the formulation which Merck uses: “could potentially reduce cervical cancer incidence”: It has not been proved that Gardasil prevents a single case of cancer.
It has not been tested for carcinogenicity.
Replacement occurs where virus strains are always replaced by new ones. It is unknown whether the new strains will be more carcinogenic than the old ones. On the contrary, it may well increase the risk of cancer.
Added to the fact that polysorbate facilitates passage of neurotoxic aluminium into the brain tissue, this potentially increasing the risk of brain damage – the best solution is NO dose of this vaccine!